Related references
Note: Only part of the references are listed.The Role of NK Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia
Alireza Zafarani et al.
STEM CELL REVIEWS AND REPORTS (2023)
Advances in NK cell production
Fang Fang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
NK-cell exhaustion, B-cell exhaustion and T-cell exhaustion-the differences and similarities
Kevin Roe
IMMUNOLOGY (2022)
Natural killer cells: a promising immunotherapy for cancer
Junfeng Chu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Nina Lamers-Kok et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors
Tsutomu Nakazawa et al.
REGENERATIVE THERAPY (2022)
Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Temozolomide-induced aplastic anaemia: Case report and review of the literature
Peter J. Gilbar et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2021)
NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
CRISPR-Cas9-Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells
Takayuki Morimoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Evaluation of Comprehensive Gene Expression and NK Cell-Mediated Killing in Glioblastoma Cell Line-Derived Spheroids
Takayuki Morimoto et al.
CANCERS (2021)
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy
Karrune Woan et al.
CELL STEM CELL (2021)
Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors
Yoichi Shida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Mitochondria as Playmakers of CAR T-cell Fate and Longevity
Hosein Rostamian et al.
CANCER IMMUNOLOGY RESEARCH (2021)
NK Cells in a Tug-of-War With Cancer: The Roles of Transcription Factors and Cytoskeleton
E. Hui Clarissa Lee et al.
FRONTIERS IN IMMUNOLOGY (2021)
MicroRNA-130a enhances the killing ability of natural killer cells against non-small cell lung cancer cells by targeting signal transducers and activators of transcription
Xiaohu Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth
Tsutomu Nakazawa et al.
CELLS (2020)
Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro
Yoshitaka Tanaka et al.
PLOS ONE (2019)
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
Daniela Pende et al.
FRONTIERS IN IMMUNOLOGY (2019)
Killers 2.0: NK cell therapies at the forefront of cancer control
Jonathan J. Hodgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
A simple method for in vitro preparation of natural killer cells from cord blood
Yong Xu Mu et al.
BMC BIOTECHNOLOGY (2019)
Technical advances in NK cell-based cellular immunotherapy
Fang Fang et al.
CANCER BIOLOGY & MEDICINE (2019)
Activating and inhibitory receptors expressed on innate lymphoid cells
Sophie Guia et al.
SEMINARS IN IMMUNOPATHOLOGY (2018)
Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer
Shuzhen Liang et al.
ONCOTARGETS AND THERAPY (2017)
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer immunotherapy: Recent innovations and Future Developments
John P. Veluchamy et al.
FRONTIERS IN IMMUNOLOGY (2017)
Entire CD3ε, δ, and γ humanized mouse to evaluate human CD3-mediated therapeutics
Otoya Ueda et al.
SCIENTIFIC REPORTS (2017)
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma
Nina Shah et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Donor Killer Immunoglobulin-Like Receptor Haplotype B/x Induces Severe Acute Graft-versus-Host Disease in the Presence of Human Leukocyte Antigen Mismatch in T Cell-Replete Hematopoietic Cell Transplantation
Ryosuke Hosokai et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Petra S. A. Becker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
Shannon L. Maude et al.
BLOOD (2015)
Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
Naoyuki Sakamoto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation
Nirali N. Shah et al.
BLOOD (2015)
Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
Nina Shah et al.
PLOS ONE (2013)
Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
David A. Knorr et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
NK cell MHC class I specific receptors (KIR): from biology to clinical intervention
Ariane Thielens et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation
Martha Luevano et al.
HUMAN IMMUNOLOGY (2012)
Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
Maria R. Parkhurst et al.
CLINICAL CANCER RESEARCH (2011)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
Characterization of cord blood natural killer cells:: Implications for transplantation and neonatal infections
JH Dalle et al.
PEDIATRIC RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells:: a clinical phase I trial
SW Krause et al.
CLINICAL CANCER RESEARCH (2004)
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial
LJ Burns et al.
BONE MARROW TRANSPLANTATION (2003)